News

On June 16, UBS maintained its Buy rating and $29 price target for Mattel Inc. following a meeting with the company’s new CFO ...
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Kenvue Inc. (NYSE:KVUE) is one of the 12 best consumer goods stocks billionaires are quietly buying. On June 24, the company ...
Tylenol-maker Kenvue CEO Thibaut Mongon departs in company’s second big executive shuffle after company replaced finance ...
Echoing this, short-term traders are also sporting a call-bias. This is per the security's Schaeffer's put/call open interest ...
Kenvue names interim CEO, begins strategic review to simplify operations and considers divesting smaller beauty brands amid ...
The Manila Times on MSN5d
Tylenol maker Kenvue ousts CEO
BAND-AID and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what some investors expect will be the groundwork for an eventual sale of the ...
The Summit, N.J., drugmaker on Monday named director Kirk Perry interim chief executive officer after Mongon's departure from the company and board. The company also said a strategic review is ...
The period after Origin is supposed to be a thrilling, white-knuckle ride to the finals where teams are desperately trying to snare one ...
Kenvue's has fired CEO Thibaut Mongon, who has also stepped down from the board, the consumer health company said on Monday, ...